Longevity Treatment Guides

Pick a CLIA laboratory and indicated tests with a clinician who will counsel genetics results. Fear-based mega-panels are not a substitute for guideline screening.

USPSTF-aligned preventive visits target indicated screening and counseling. Cash-pay executive packages add tests that can create incidental findings and extra follow-up.

Lab cardiopulmonary testing measures expired gases during a graded effort. Wrist wearables estimate fitness from heart rate and algorithms. A wearable number is not a CPET.

Clinic DXA is generally more precise for bone, fat, and lean mass. BIA is convenient but changes with hydration. Neither scan replaces a medical evaluation of your health.

Clinical genetic tests read inherited DNA and need counseling. Methylation biological-age clocks are research-grade estimates and should not replace screening.

A1C, fasting glucose, and OGTT diagnose prediabetes and diabetes when indicated. Boutique insulin-resistance labels do not replace ADA or USPSTF criteria.

Use USPSTF-aligned, cancer-specific screening first. Cash-pay full-body scans and MCED blood tests can create incidental findings without proven mortality benefit.

ASCVD risk starts with blood pressure, lipids, and A1C. CAC or hsCRP can help selected adults. Testing is not a substitute for indicated treatment. Chest pain is an emergency.

A false positive is a wrong alarm. Overdiagnosis finds real disease that would never have harmed you. Incidental findings start cascades you should plan before testing.

A lab reference interval is not a wellness “optimal” range. Treating numbers without a clinical indication can mean unnecessary drugs, procedures, and harm.

Chronological age is calendar time. Biological-age scores are model estimates with limited clinical action. They should not replace recommended screening or treatment.

Cardiorespiratory fitness associates with better outcomes. A lab CPET is not a wristwatch estimate. Training can raise fitness; it is not a lifespan guarantee.

Separate USPSTF and indicated labs from boutique longevity panels. More markers do not mean better care. Ask which result will change a clinical decision this year.

Screening and diagnostic tests can estimate risk, detect disease, monitor treatment, or measure function. High-value testing starts with a question and includes interpretation, follow-up, and protection from false positives and overdiagnosis.

VO2 max testing measures peak oxygen consumption during progressive exercise with gas analysis. It can assess cardiorespiratory fitness and exercise limitation when protocol, effort, calibration, and safety monitoring are appropriate.

Dual-energy X-ray absorptiometry measures bone mineral density and can estimate body composition using low-dose ionizing radiation. Bone and body-composition protocols, outputs, and repeat intervals differ.

An executive physical bundles history, examination, preventive planning, labs, and sometimes imaging or performance tests. Quality depends on evidence-based selection, continuity, and follow-up—not the number of tests.

Performance testing measures cardiorespiratory fitness, thresholds, body composition, strength, power, movement, or sport-specific capacity. Useful programs standardize protocols and turn results into training decisions.

Diagnostic imaging includes X-ray, ultrasound, DEXA, CT, MRI, and nuclear studies. The right scan answers a defined question or follows a validated screening guideline while minimizing radiation, contrast, incidental findings, and unnecessary follow-up.

Genetic testing examines selected variants, genes, panels, exomes, or genomes for a defined purpose. Test scope, ancestry, laboratory method, counseling, privacy, and confirmatory testing determine clinical value.

Biomarker testing measures selected blood, urine, or other indicators to answer a clinical question. Useful testing links each result to pretest probability, standardized collection, interpretation, and an action plan.

Research-oriented tests use DNA methylation, proteins, metabolites, physiology, or clinical data to estimate biological age or aging pace. Results are model-dependent and are not a diagnosis or proven treatment target.